Coronary Artery Disease

A comprehensive secondary prevention program achieved significantly increased weight-loss rates in patients with CAD who were overweight, researchers reported in Heart.

Like other specialties in medicine, cardiology has seen an influx in interest in less invasive therapeutic options.

Patients with HF and CAD who increased their daily levels of physical activity after receiving an implantable cardioverter defibrillator had better 1-year survival vs. those who did not, researchers reported.

More extensive stenting improved coronary perfusion and reduced myocardial injury among high-risk patients with spontaneous coronary artery dissection, but was linked to elevated risk for procedural complications, researchers reported.

The evaluation and management of CAD has critical implications in certain populations. A recently published review addresses this topic for two high-risk populations, commercial motor vehicle drivers and commercial pilots.

In a prospective cohort study of patients hospitalized with HF with preserved ejection fraction, a majority of participants had evidence of epicardial CAD, coronary microvascular disease or both.

Among patients with stable CAD assigned to an invasive strategy in the ISCHEMIA trial, those who achieved complete revascularization had better clinical and quality of life outcomes, researchers reported.

Microvascular angina is a significant health problem that confers risk for major adverse CV events, according to registry data from the Coronary Vasomotor Disorders International Study, or COVADIS, Group.

Among stable outpatients with CAD, 21.2% reported experiencing angina at least once monthly, researchers reported.

In patients with HF from the VICTORIA trial, those with CAD had worse outcomes, according to a presentation at the American College of Cardiology Scientific Session.